Crexendo (CXDO) director receives 10,000 stock options at $6.47 exercise price

Rhea-AI Filing Summary

Crexendo, Inc. director Kevin Arnold Jackson reported receiving a grant of stock options on March 4, 2026. The award covers 10,000 stock options with an exercise price of $6.47 per share, giving him the right to buy company stock at that price in the future.

According to the filing, these options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the award becomes exercisable gradually over three years rather than all at once. After this grant, he holds 10,000 stock options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Jackson Kevin Ar nold

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options	10,000	$6.47	$65K

Holdings After Transaction: Stock Options — 10,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jackson Kevin Ar nold

(Last) (First) (Middle)

1225 W WASHINGTON ST

STE 213

(Street)

TEMPE AZ 85288

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Crexendo, Inc. [ CXDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$6.47	03/04/2026		A		10,000		(1)	03/04/2036	Common Stock	10,000	$6.47	10,000	D

Explanation of Responses:

1. The stock options vest over 36 equal monthly installments beginning on 4/4/2026.

	/s/ Kevin Jackson	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Crexendo (CXDO) report for Kevin Arnold Jackson?

Crexendo reported that director Kevin Arnold Jackson received a grant of 10,000 stock options on March 4, 2026. These options give him the right to buy company shares at a fixed price if and when they vest and are exercised.

What is the exercise price of the new Crexendo (CXDO) stock options?

The granted stock options have an exercise price of $6.47 per share. This means Jackson can purchase Crexendo shares at $6.47 once the options vest and he chooses to exercise them, regardless of the future market trading price.

How do the Crexendo (CXDO) stock options granted to Kevin Arnold Jackson vest?

The stock options vest over 36 equal monthly installments starting on April 4, 2026. This structure spreads vesting across three years, so portions of the 10,000-option award become exercisable each month instead of all at once.

How many Crexendo (CXDO) stock options does Kevin Arnold Jackson hold after this Form 4?

After the reported grant, Jackson holds 10,000 stock options directly. These options represent potential future ownership, since he must wait for them to vest and then choose to exercise them to convert the options into Crexendo common shares.

Was the Crexendo (CXDO) insider transaction a market purchase or an award?

The transaction was a grant or award of stock options, not an open-market share purchase or sale. It reflects equity-based compensation, giving Jackson the right to buy shares at $6.47 once the options vest over the specified 36-month schedule.